Compounding Pharmacy Inside Large Medical Center [Sterile/Non Sterile]
ESTABLISHED COMPOUNDING PHARMACY - SAN DIEGO MEDICAL CENTER LOCATION
This well-established retail and compounding pharmacy, operating since 1984, presents an exceptional acquisition opportunity within San Diego's premier medical corridor near UCSD. The business occupies a strategic 1,400 square foot location within a major medical center complex, benefiting from proximity to over 20 prescribers including surgical, dental, and veterinary practices.
OPERATIONAL HIGHLIGHTS:
- Comprehensive insurance network including Medicare, Medicaid, Express Scripts, Optum, Caremark, and Humana
- PSAO partnership with Align RX ensuring competitive reimbursement rates
- Clean regulatory standing with no Board violations
- Current DEA, Medicare, and MediCal certifications in good standing
- Pioneer RX pharmacy management system
- Cardinal Health as primary pharmaceutical wholesaler
FACILITY & INFRASTRUCTURE:
- Professional-grade fixtures and security systems
- Dedicated non-sterile compounding capabilities processing 6-10 scripts daily
- PCCA membership providing specialized compounding resources
- Sterile compounding room infrastructure (requires recertification)
- Eight-year lease term remaining with assignment opportunity for qualified buyers
Certified as a Sterile Compounding in 2016, must be re-certified, currently operates as a Non Sterile Compounding Pharmacy.
OPERATIONS:
- Monday through Friday operation (9 AM - 5 PM)
- Established patient base with consistent prescription volume
- Experienced Pharmacist-in-Charge available for transition support
- Motivated seller facilitating smooth ownership transfer
This turnkey operation combines the stability of retail pharmacy services with the higher-margin specialty of pharmaceutical compounding. The medical center location provides consistent referral sources and growth potential within San Diego's robust healthcare market.
Financial documentation, inventory records, and detailed operational data available to qualified buyers upon execution of confidentiality agreement. Proof of funds required for initial review.
